Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines

Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycop...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2016-10, Vol.11 (10), p.e0164245-e0164245
Hauptverfasser: Rouxel, Ronan N, Mérour, Emilie, Biacchesi, Stéphane, Brémont, Michel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e0164245
container_issue 10
container_start_page e0164245
container_title PloS one
container_volume 11
creator Rouxel, Ronan N
Mérour, Emilie
Biacchesi, Stéphane
Brémont, Michel
description Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20°C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.
doi_str_mv 10.1371/journal.pone.0164245
format Article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1826490511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A471829428</galeid><doaj_id>oai_doaj_org_article_7d0a2adf5c8c44b7a2c8d0b8c1daa58e</doaj_id><sourcerecordid>A471829428</sourcerecordid><originalsourceid>FETCH-LOGICAL-c726t-d6dda2e256dc04d13ca41f929e54123678be2545835a52923689c789cc0506363</originalsourceid><addsrcrecordid>eNqNk1tv0zAUxyMEYmPwDRBEQkLsoa2vubwgVRXQSmObNuir5dpO48qxu9gpsI_Ap8ZZu6md9oCiyNY5v_O3fS5J8haCIcQ5HK1c11puhmtn1RDAjCBCnyXHsMRokCGAn-_tj5JX3q8AoLjIspfJEcpzCGGeHSd_J65ZGxVUetm6oETQzqZ8ybX1IZ3ZynTK3vJ0rtvOp1N4DtPr0EZvOh5dXo2KESbppObGKLtUaTR_10Kls6bprL5VMv2lQ52eOzsYy1W34TZE27nb6LbmC9mvUXXOhdBW-dfJi4obr97s1pPk59cvPybTwdnFt9lkfDYQOcrCQGZScqQQzaQAREIsOIFViUpFCUQ4y4tFdBJaYMopKqOlKEUefwEoyHCGT5L3W921cZ7t0ugZLFBGSkAhjMRsS0jHV2zd6oa3f5jjmt0ZXLtkvA1aGMVyCTjisqKiEIQsco5EIcGiEFByTgsVtT7vTusWjZJC2Zg_cyB66LG6Zku3YTRWi8I8CpxuBepHYdPxGettsfYAYYI3_cU_7Q5r3U2nfGCN9kIZw61yXf9GTGPvwLssfHiEPp2JHbXk8bHaVi7eUfSibEzyCJYEFZEaPkHFT6pGi9iflY72g4DTg4DIBPU7LHnnPZtdX_0_ezE_ZD_usbXiJtTema7van8Iki0oWud9q6qHzELA-vG6zwbrx4vtxiuGvdsv5kPQ_Tzhf7lXHg4</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1826490511</pqid></control><display><type>article</type><title>Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS) Journals Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Rouxel, Ronan N ; Mérour, Emilie ; Biacchesi, Stéphane ; Brémont, Michel</creator><contributor>Tsuji, Moriya</contributor><creatorcontrib>Rouxel, Ronan N ; Mérour, Emilie ; Biacchesi, Stéphane ; Brémont, Michel ; Tsuji, Moriya</creatorcontrib><description>Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20°C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0164245</identifier><identifier>PMID: 27711176</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Animals ; Antibodies, Neutralizing - blood ; Antibodies, Neutralizing - immunology ; Antibody response ; Antigens ; Biology and life sciences ; Carps ; Cell Line ; Dogs ; Female ; Fluorescent Antibody Technique, Indirect ; Genetics ; Genomes ; Glycoproteins ; Hemagglutinins ; Hemagglutinins - genetics ; Hemagglutinins - immunology ; Hemagglutinins - metabolism ; Hemorrhage ; Hemorrhagic septicemia ; Immunization ; Infections ; Infectious hematopoietic necrosis ; Influenza ; Influenza A Virus, H1N1 Subtype - immunology ; Influenza A Virus, H1N1 Subtype - pathogenicity ; Influenza vaccines ; Influenza viruses ; Lectins ; Lethal dose ; Life Sciences ; Madin Darby Canine Kidney Cells ; Medical research ; Medicine and Health Sciences ; Mice ; Mice, Inbred BALB C ; Microscopy, Electron ; Mutagenesis ; Novirhabdovirus - immunology ; Novirhabdovirus - metabolism ; Orthomyxoviridae Infections - immunology ; Orthomyxoviridae Infections - prevention &amp; control ; Pandemics ; Plasmids - genetics ; Plasmids - metabolism ; Production capacity ; Proteins ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - genetics ; Recombinant Proteins - immunology ; Research and Analysis Methods ; Septicemia ; Swine flu ; Vaccination ; Vaccines ; Vaccines, Synthetic - immunology ; Viruses ; West Nile fever ; West Nile virus ; Wildlife conservation</subject><ispartof>PloS one, 2016-10, Vol.11 (10), p.e0164245-e0164245</ispartof><rights>COPYRIGHT 2016 Public Library of Science</rights><rights>2016 Rouxel et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Attribution</rights><rights>2016 Rouxel et al 2016 Rouxel et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c726t-d6dda2e256dc04d13ca41f929e54123678be2545835a52923689c789cc0506363</citedby><cites>FETCH-LOGICAL-c726t-d6dda2e256dc04d13ca41f929e54123678be2545835a52923689c789cc0506363</cites><orcidid>0000-0002-7020-2391</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053517/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5053517/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27711176$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-01602343$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Tsuji, Moriya</contributor><creatorcontrib>Rouxel, Ronan N</creatorcontrib><creatorcontrib>Mérour, Emilie</creatorcontrib><creatorcontrib>Biacchesi, Stéphane</creatorcontrib><creatorcontrib>Brémont, Michel</creatorcontrib><title>Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20°C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.</description><subject>Animals</subject><subject>Antibodies, Neutralizing - blood</subject><subject>Antibodies, Neutralizing - immunology</subject><subject>Antibody response</subject><subject>Antigens</subject><subject>Biology and life sciences</subject><subject>Carps</subject><subject>Cell Line</subject><subject>Dogs</subject><subject>Female</subject><subject>Fluorescent Antibody Technique, Indirect</subject><subject>Genetics</subject><subject>Genomes</subject><subject>Glycoproteins</subject><subject>Hemagglutinins</subject><subject>Hemagglutinins - genetics</subject><subject>Hemagglutinins - immunology</subject><subject>Hemagglutinins - metabolism</subject><subject>Hemorrhage</subject><subject>Hemorrhagic septicemia</subject><subject>Immunization</subject><subject>Infections</subject><subject>Infectious hematopoietic necrosis</subject><subject>Influenza</subject><subject>Influenza A Virus, H1N1 Subtype - immunology</subject><subject>Influenza A Virus, H1N1 Subtype - pathogenicity</subject><subject>Influenza vaccines</subject><subject>Influenza viruses</subject><subject>Lectins</subject><subject>Lethal dose</subject><subject>Life Sciences</subject><subject>Madin Darby Canine Kidney Cells</subject><subject>Medical research</subject><subject>Medicine and Health Sciences</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Microscopy, Electron</subject><subject>Mutagenesis</subject><subject>Novirhabdovirus - immunology</subject><subject>Novirhabdovirus - metabolism</subject><subject>Orthomyxoviridae Infections - immunology</subject><subject>Orthomyxoviridae Infections - prevention &amp; control</subject><subject>Pandemics</subject><subject>Plasmids - genetics</subject><subject>Plasmids - metabolism</subject><subject>Production capacity</subject><subject>Proteins</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - immunology</subject><subject>Research and Analysis Methods</subject><subject>Septicemia</subject><subject>Swine flu</subject><subject>Vaccination</subject><subject>Vaccines</subject><subject>Vaccines, Synthetic - immunology</subject><subject>Viruses</subject><subject>West Nile fever</subject><subject>West Nile virus</subject><subject>Wildlife conservation</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNk1tv0zAUxyMEYmPwDRBEQkLsoa2vubwgVRXQSmObNuir5dpO48qxu9gpsI_Ap8ZZu6md9oCiyNY5v_O3fS5J8haCIcQ5HK1c11puhmtn1RDAjCBCnyXHsMRokCGAn-_tj5JX3q8AoLjIspfJEcpzCGGeHSd_J65ZGxVUetm6oETQzqZ8ybX1IZ3ZynTK3vJ0rtvOp1N4DtPr0EZvOh5dXo2KESbppObGKLtUaTR_10Kls6bprL5VMv2lQ52eOzsYy1W34TZE27nb6LbmC9mvUXXOhdBW-dfJi4obr97s1pPk59cvPybTwdnFt9lkfDYQOcrCQGZScqQQzaQAREIsOIFViUpFCUQ4y4tFdBJaYMopKqOlKEUefwEoyHCGT5L3W921cZ7t0ugZLFBGSkAhjMRsS0jHV2zd6oa3f5jjmt0ZXLtkvA1aGMVyCTjisqKiEIQsco5EIcGiEFByTgsVtT7vTusWjZJC2Zg_cyB66LG6Zku3YTRWi8I8CpxuBepHYdPxGettsfYAYYI3_cU_7Q5r3U2nfGCN9kIZw61yXf9GTGPvwLssfHiEPp2JHbXk8bHaVi7eUfSibEzyCJYEFZEaPkHFT6pGi9iflY72g4DTg4DIBPU7LHnnPZtdX_0_ezE_ZD_usbXiJtTema7van8Iki0oWud9q6qHzELA-vG6zwbrx4vtxiuGvdsv5kPQ_Tzhf7lXHg4</recordid><startdate>20161006</startdate><enddate>20161006</enddate><creator>Rouxel, Ronan N</creator><creator>Mérour, Emilie</creator><creator>Biacchesi, Stéphane</creator><creator>Brémont, Michel</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7020-2391</orcidid></search><sort><creationdate>20161006</creationdate><title>Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines</title><author>Rouxel, Ronan N ; Mérour, Emilie ; Biacchesi, Stéphane ; Brémont, Michel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c726t-d6dda2e256dc04d13ca41f929e54123678be2545835a52923689c789cc0506363</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Animals</topic><topic>Antibodies, Neutralizing - blood</topic><topic>Antibodies, Neutralizing - immunology</topic><topic>Antibody response</topic><topic>Antigens</topic><topic>Biology and life sciences</topic><topic>Carps</topic><topic>Cell Line</topic><topic>Dogs</topic><topic>Female</topic><topic>Fluorescent Antibody Technique, Indirect</topic><topic>Genetics</topic><topic>Genomes</topic><topic>Glycoproteins</topic><topic>Hemagglutinins</topic><topic>Hemagglutinins - genetics</topic><topic>Hemagglutinins - immunology</topic><topic>Hemagglutinins - metabolism</topic><topic>Hemorrhage</topic><topic>Hemorrhagic septicemia</topic><topic>Immunization</topic><topic>Infections</topic><topic>Infectious hematopoietic necrosis</topic><topic>Influenza</topic><topic>Influenza A Virus, H1N1 Subtype - immunology</topic><topic>Influenza A Virus, H1N1 Subtype - pathogenicity</topic><topic>Influenza vaccines</topic><topic>Influenza viruses</topic><topic>Lectins</topic><topic>Lethal dose</topic><topic>Life Sciences</topic><topic>Madin Darby Canine Kidney Cells</topic><topic>Medical research</topic><topic>Medicine and Health Sciences</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Microscopy, Electron</topic><topic>Mutagenesis</topic><topic>Novirhabdovirus - immunology</topic><topic>Novirhabdovirus - metabolism</topic><topic>Orthomyxoviridae Infections - immunology</topic><topic>Orthomyxoviridae Infections - prevention &amp; control</topic><topic>Pandemics</topic><topic>Plasmids - genetics</topic><topic>Plasmids - metabolism</topic><topic>Production capacity</topic><topic>Proteins</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - immunology</topic><topic>Research and Analysis Methods</topic><topic>Septicemia</topic><topic>Swine flu</topic><topic>Vaccination</topic><topic>Vaccines</topic><topic>Vaccines, Synthetic - immunology</topic><topic>Viruses</topic><topic>West Nile fever</topic><topic>West Nile virus</topic><topic>Wildlife conservation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rouxel, Ronan N</creatorcontrib><creatorcontrib>Mérour, Emilie</creatorcontrib><creatorcontrib>Biacchesi, Stéphane</creatorcontrib><creatorcontrib>Brémont, Michel</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rouxel, Ronan N</au><au>Mérour, Emilie</au><au>Biacchesi, Stéphane</au><au>Brémont, Michel</au><au>Tsuji, Moriya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2016-10-06</date><risdate>2016</risdate><volume>11</volume><issue>10</issue><spage>e0164245</spage><epage>e0164245</epage><pages>e0164245-e0164245</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Novirhabdoviruses like Viral Hemorrhagic Septicemia Virus (VHSV) and Infectious Hematopoietic Necrosis Virus (IHNV) are fish-infecting Rhabdoviruses belonging to the Mononegavirales order. By reverse genetics, we previously showed that a recombinant VHSV expressing the West Nile Virus (WNV) E glycoprotein could serve as a vaccine platform against WNV. In the current study, we aimed to evaluate the potential of the Novirhabdovirus platform as a vaccine against influenza virus. Recombinant Novirhabdoviruses, rVHSV-HA and rIHNV-HA, expressing at the viral surface the hemagglutinin HA ectodomain were generated and used to immunized mice. We showed that mice immunized with either, rVHSV-HA or rIHNV-HA, elicited a strong neutralizing antibody response against influenza virus. A complete protection was conferred to the immunized mice when challenged with a lethal dose of influenza H1N1 A/PR/8/34 virus. Furthermore we showed that although acting as inert antigen in mice, since naturally inactivated over 20°C, mice immunized with rVHSV-HA or rIHNV-HA in the absence of adjuvant were also completely protected from a lethal challenge. Novirhabdoviruses platform are of particular interest as vaccines for mammals since they are cost effective to produce, relatively easy to generate and very effective to protect immunized animals.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>27711176</pmid><doi>10.1371/journal.pone.0164245</doi><tpages>e0164245</tpages><orcidid>https://orcid.org/0000-0002-7020-2391</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2016-10, Vol.11 (10), p.e0164245-e0164245
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1826490511
source MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS) Journals Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry
subjects Animals
Antibodies, Neutralizing - blood
Antibodies, Neutralizing - immunology
Antibody response
Antigens
Biology and life sciences
Carps
Cell Line
Dogs
Female
Fluorescent Antibody Technique, Indirect
Genetics
Genomes
Glycoproteins
Hemagglutinins
Hemagglutinins - genetics
Hemagglutinins - immunology
Hemagglutinins - metabolism
Hemorrhage
Hemorrhagic septicemia
Immunization
Infections
Infectious hematopoietic necrosis
Influenza
Influenza A Virus, H1N1 Subtype - immunology
Influenza A Virus, H1N1 Subtype - pathogenicity
Influenza vaccines
Influenza viruses
Lectins
Lethal dose
Life Sciences
Madin Darby Canine Kidney Cells
Medical research
Medicine and Health Sciences
Mice
Mice, Inbred BALB C
Microscopy, Electron
Mutagenesis
Novirhabdovirus - immunology
Novirhabdovirus - metabolism
Orthomyxoviridae Infections - immunology
Orthomyxoviridae Infections - prevention & control
Pandemics
Plasmids - genetics
Plasmids - metabolism
Production capacity
Proteins
Recombinant Proteins - biosynthesis
Recombinant Proteins - genetics
Recombinant Proteins - immunology
Research and Analysis Methods
Septicemia
Swine flu
Vaccination
Vaccines
Vaccines, Synthetic - immunology
Viruses
West Nile fever
West Nile virus
Wildlife conservation
title Complete Protection against Influenza Virus H1N1 Strain A/PR/8/34 Challenge in Mice Immunized with Non-Adjuvanted Novirhabdovirus Vaccines
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T03%3A16%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Complete%20Protection%20against%20Influenza%20Virus%20H1N1%20Strain%20A/PR/8/34%20Challenge%20in%20Mice%20Immunized%20with%20Non-Adjuvanted%20Novirhabdovirus%20Vaccines&rft.jtitle=PloS%20one&rft.au=Rouxel,%20Ronan%20N&rft.date=2016-10-06&rft.volume=11&rft.issue=10&rft.spage=e0164245&rft.epage=e0164245&rft.pages=e0164245-e0164245&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0164245&rft_dat=%3Cgale_plos_%3EA471829428%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1826490511&rft_id=info:pmid/27711176&rft_galeid=A471829428&rft_doaj_id=oai_doaj_org_article_7d0a2adf5c8c44b7a2c8d0b8c1daa58e&rfr_iscdi=true